Analyst: Gilead’s new crown drug could soon get FDA approval

Tyler Van Buren, an analyst at Piper Sandler, said on Wednesday that Gilead’s treatment “could soon be approved for the new coronavirus” after he said fujifilm’s similar drug was used in 200 patients and produced “very encouraging” data.

Analyst: Gilead's new crown drug could soon get FDA approval

“We now think the results of the Redsey clinical trial may be positive.” “If successful, if it is safe, the threshold for efficacy in the context of a global pandemic of the virus will be lower and may be approved for widespread use in the coming months,” he said.

Gilead’s shares jumped more than 6 per cent on Wednesday.